CI250117C380000
- 0.05
- 0.000.00%
Cigna Group Newsroom
Bernstein Maintains Cigna Group(CI.US) With Buy Rating, Cuts Target Price to $345
The USA FTC pointed out that the three major pharmaceutical benefit management Institutions in the USA have significantly increased their prices.
On January 15, Gelonghui reported that the USA Federal Trade Commission (FTC) stated on Tuesday that the three major Pharmaceutical benefits management Institutions in the USA, including UnitedHealth Group, CVS Health, and Cigna, significantly raised the prices of certain medications in their pharmacies, including those for heart disease, cancer, and HIV. The Commission noted that from 2017 to 2022, UnitedHealth's Optum, CVS Health's CVS Caremark, and Cigna's Express Scripts increased the prices in their pharmacies several times to dozens of times, resulting in net income exceeding Pharmaceutical procurement costs by 7.3 billion dollars.
Sector Update: Health Care Stocks Slide Late Afternoon
PBMs Generated Billions in Drug Markups, FTC Says -- Barrons.com
Is The Cigna Group (CI) the Best Safe Dividend Stock for 2025?
FTC Finds PBMs Excessively Marked up Prices on Specialty Drugs
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Express News | FTC Report Says Pbms Likely Steer More Profitable Prescriptions to Their Affiliated Pharmacies
Express News | US FTC Report Finds Three Major Pbms Inflated Drug Prices by $7.3 Bln From 2017-2022
Express News | The Cigna Group's Fourth Quarter 2024 Earnings Release Details
Express News | Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
J.P. Morgan Healthcare Conference Kicks Off. The Industry Isn't Well. -- Barrons.com
CMS Proposes 4.33% Increase for Medicare Advantage Plans
High-cost Weight Loss Drugs Are Sending Employers to Nutrition Counseling in a Boost for Startups
Looking Into Cigna's Recent Short Interest
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant Recipients
Cigna Stock Plunges 18.7% in 3 Months: Should You Buy, Hold or Sell?
Investors in Cigna Group (NYSE:CI) Have Seen Decent Returns of 47% Over the Past Five Years
Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping?
Evercore's AI Enablers, Adopters and Adapters: CRM, MU, CI, EQT and More